Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/18/2008 | CN100394981C Human granulocyte-macrophage colony stimulating factor spray and its preparation process |
06/18/2008 | CN100394979C Use of composition in preparing medicament for preventing and treating lethargy |
06/18/2008 | CN100394977C Turmeric-containing composition |
06/18/2008 | CN100394968C Medicinal composition for treating rheumatic, rheumatoid arthritis |
06/18/2008 | CN100394967C Chinese medicine composition for treating wrinary tract disease |
06/18/2008 | CN100394966C Chinese medicine preparation for treating wind-cold disease, and its preparing method |
06/18/2008 | CN100394964C Method for preparing epicarp citri pills concentrates |
06/18/2008 | CN100394963C Medicine for treating female chronic fatigue syndrome and its preparing process |
06/18/2008 | CN100394962C Application of 'Wang Shi Bao Chi Wan' in preparation of medicine for treating hyperlipemia, high blood viscosity syndrome, high blood sugar and hypertension |
06/18/2008 | CN100394961C Use of composition in preparing medicament for preventing and treating psoriasis |
06/18/2008 | CN100394956C Externally-applied medicine for treating psoriasis |
06/18/2008 | CN100394954C External compressing red ointment |
06/18/2008 | CN100394953C Fat-reducing health-care product |
06/18/2008 | CN100394952C Flexible fabric bandage with Chinese medicine and its preparation |
06/18/2008 | CN100394950C Preparation method for wound external-wash Chinese-medicinal preparation and granules |
06/18/2008 | CN100394949C Preparation method of compound vitex negundo capsule |
06/18/2008 | CN100394947C Medicinal composition for treating cervical vertebra disease and its preparation method |
06/18/2008 | CN100394939C Pure Chinese medicine oral preparation for treating prostate disease and its preparation metod |
06/18/2008 | CN100394937C Medicine for preventing and treating cardiac and cerebral vascular diseases |
06/18/2008 | CN100394936C Medicine for treating flooding and spotting and its preparation method |
06/18/2008 | CN100394935C Method for extracting injection medicine from Chinese herb medicines for intravenous drip |
06/18/2008 | CN100394932C Medicinal composition for treating keratitis caused by herpes zoster |
06/18/2008 | CN100394931C Puerariae Decoction mixture preparing process |
06/18/2008 | CN100394929C Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
06/18/2008 | CN100394927C Liver cancer resistant Antrodia camphorata and preparation method thererof |
06/18/2008 | CN100394925C Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis |
06/18/2008 | CN100394924C Application of high permeability medicine composition in preparing pre-nacrosis medicine |
06/18/2008 | CN100394921C Freeze-drying powder for injecting lentinan and its content determination |
06/18/2008 | CN100394919C Medicinal composition for treating vagina disease |
06/18/2008 | CN100394918C Preparation of phosphosphingolipid isopropylphenol fatty emulsion and its preparation method |
06/18/2008 | CN100394917C Bilobanoate oral-cavity disintegrating tablet and preparation method |
06/18/2008 | CN100394915C Use of gingerol oxime in preparing anti-blood platelet aggregation medicine |
06/18/2008 | CN100394914C Aarin oral cavity disintegrating tablet and preparation method thereof |
06/18/2008 | CN100394868C Green plum juice effervescence tablets and its preparation method |
06/17/2008 | USRE40387 7,11-dihydroxy 8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl) ethenyl-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione and neutralizing buffer in an amount sufficient to reduce its decomposition; increasing the bioavailability of orally administered epothilones; anticarcinogenic agent |
06/17/2008 | US7388075 Medicament containing activated antithrombin III |
06/17/2008 | US7388042 Nanotechnology for biomedical implants |
06/17/2008 | US7388032 Sustained release compositions, process for producing the same and utilization thereof |
06/17/2008 | US7387994 Antitumor, anticancer agents; particles or coils or stents coated solid-phase agent comprising a binding agent comprising collagen are directed to target vasculature, such as the vasculature of solid tumor masses or aneurysms |
06/17/2008 | US7387900 Colloidal metal compositions and methods |
06/17/2008 | US7387807 Topical composition comprising feverfew |
06/17/2008 | US7387806 Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments |
06/17/2008 | US7387803 Dietary fiber delivery system |
06/17/2008 | US7387797 Compositions derived from Modiolus modiolus and methods for making and using same |
06/17/2008 | US7387796 Stable compositions of S-adenosyl-l-methionine with dextran |
06/17/2008 | US7387795 Cosmetic compositions organophosphonic acid coated particulates and methods for producing the same |
06/17/2008 | US7387794 Preparation of powder agglomerate |
06/17/2008 | US7387793 Such as capsules/beads of cyclobenzaprine hydrochloride |
06/17/2008 | US7387792 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
06/17/2008 | US7387790 Non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect; anticancer agents |
06/17/2008 | US7387789 Transdermal delivery of non-steroidal anti-inflammatory drugs |
06/17/2008 | US7387787 Mixture of polymer, polyvinyl alcohol, propylene glycol, humectant,cleaningh compound for skin; generating foam upon exposure to water |
06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
06/17/2008 | US7387673 Controlling particle size of powder; mixing, heating metal particles in matrix |
06/17/2008 | US7387086 Bovine germicide application device and method |
06/17/2008 | CA2439904C Immobilizing objects in the body |
06/17/2008 | CA2439818C Large, porous particles produced controlling humidity during a spray drying process |
06/17/2008 | CA2414063C Highly concentrated stable meloxicam solutions |
06/17/2008 | CA2391076C Solutions containing epinastin |
06/17/2008 | CA2384188C Antiviral compositions |
06/17/2008 | CA2314112C A method for making a pharmaceutical formulation |
06/17/2008 | CA2306566C Low temperature coatings |
06/17/2008 | CA2303884C Inorganic-polymer complexes for the controlled release of compounds including medicinals |
06/17/2008 | CA2294457C Pharmaceutical composition for application to mucosa |
06/17/2008 | CA2279788C Cation exchange resin preparation |
06/17/2008 | CA2264253C Skin patch featuring an adhesive matrix |
06/17/2008 | CA2251886C An oral pharmaceutical formulation containing ibandronate |
06/17/2008 | CA2224269C Compressed dry-granulation desogestrel tablets |
06/17/2008 | CA2200189C Scopolamine plaster |
06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
06/17/2008 | CA2166388C Antifungal composition for external use retentive in stratum corneum |
06/17/2008 | CA2151826C Pharmaceutical compositions for prevention and treatment of cancerous diseases and process for their preparation |
06/17/2008 | CA2146954C Breath activated nicotine inhalers |
06/17/2008 | CA2102693C Protein formulation comprising growth hormone |
06/17/2008 | CA2100394C Cosmetic sunscreen |
06/12/2008 | WO2008070721A2 High protein concentration formulations containing mannitol |
06/12/2008 | WO2008070670A2 Enhanced immediate release formulations of topiramate |
06/12/2008 | WO2008070602A2 Topical pharmaceutical composition |
06/12/2008 | WO2008070571A2 Vesicles of self-assembling block copolymers and methods for making and using the same |
06/12/2008 | WO2008070538A2 Micellar nanoparticles comprising botulinum toxin |
06/12/2008 | WO2008070495A2 Short term slow release drug delivery system |
06/12/2008 | WO2008070402A2 Intraocular drug delivery systems |
06/12/2008 | WO2008070279A2 Method for precipitation of small medicament particles into use containers |
06/12/2008 | WO2008070270A2 Hydrogel wound dressing and biomaterials formed in situ and their uses |
06/12/2008 | WO2008070264A2 Nasal spray composition and method for treating rhinitis, sinusitis or both |
06/12/2008 | WO2008070199A2 Construction of quantum dots via a regioselective dendritic functionalized cellulose template |
06/12/2008 | WO2008070165A1 Drug-containing compositions and their use |
06/12/2008 | WO2008070118A1 Drug delivery |
06/12/2008 | WO2008070072A2 Carvedilol forms, compositions, and methods of preparation thereof |
06/12/2008 | WO2008070009A2 Treating solid tumors and monocytic leukemia using topoisomerase inhibitors in liposomes |
06/12/2008 | WO2008069972A2 Systems for effecting cessation of tobacco use |
06/12/2008 | WO2008069970A2 Nicotine formulations, kits and systems and methods for their use |
06/12/2008 | WO2008069960A2 Separable solid dosage form administration system |
06/12/2008 | WO2008069941A2 Modified release ibuprofen solid oral dosage form |
06/12/2008 | WO2008069938A2 Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide |
06/12/2008 | WO2008069921A2 Oral transmucosal nicotine dosage form |
06/12/2008 | WO2008069911A2 Dual composition with warming and analgesic effects |
06/12/2008 | WO2008069788A1 Adding bicarbonate to human blood |
06/12/2008 | WO2008069561A1 Metal oxide hollow nanocapsule and a method for preparing the same |